Integrative psychiatry grounded in evidence, not wellness culture.
Los Angeles has no shortage of wellness practitioners offering supplements, protocols, and lifestyle interventions for mental health. What is harder to find is a board-certified psychiatrist who can evaluate those interventions rigorously — distinguishing what the science actually supports from what is being marketed — and integrate the best of them into a comprehensive psychiatric treatment plan. That is what we offer at Wave.
What integrative psychiatry is — and what it is not
Integrative psychiatry refers to the incorporation of evidence-based lifestyle, nutritional, and mind-body interventions alongside conventional psychiatric treatment. When practiced well, it expands the therapeutic toolkit available to patients — offering approaches that address the biological underpinnings of mental illness through mechanisms that medications alone do not reach.
It does not mean abandoning the standards of evidence-based medicine. It does not mean recommending expensive supplement regimens without scientific support. It does not mean treating psychiatric illness as a lifestyle problem solvable by optimizing your morning routine.
Los Angeles has a thriving wellness industry that frequently blurs these lines. Influencers, functional medicine practitioners, and direct-to-consumer supplement companies regularly make claims about mental health that range from overstated to flatly unsupported by clinical evidence. Patients navigating this landscape deserve a physician who can help them think clearly about what is worth trying, what the evidence actually shows, and what carries risks they may not have been told about.
At Wave, our psychiatrists bring that clarity. We are genuinely interested in the full range of evidence-based interventions for mental health — and equally committed to being honest when the evidence does not support a popular claim.
Our integrative psychiatry approach
Every integrative recommendation at Wave begins with a thorough psychiatric evaluation. We do not overlay a wellness protocol onto an unexamined presentation. We start with an accurate diagnosis, a clear understanding of your history and current treatment, and a rigorous assessment of which integrative interventions are most likely to be beneficial for your specific situation — and which carry risks worth understanding.
What follows is an overview of the integrative domains we address in clinical practice at Wave.
Nutritional psychiatry
The relationship between nutrition and mental health is one of the most rapidly developing areas in psychiatric research. The evidence is now sufficiently robust to support meaningful clinical guidance — though it is considerably more nuanced than the supplement industry's marketing suggests.
Omega-3 fatty acids, particularly EPA and DHA, have the strongest evidence base among nutritional supplements for psychiatric conditions. Meta-analyses support their use as adjunctive treatment for major depression, with EPA-predominant formulations showing the most consistent benefit. Dose, formulation, and the ratio of EPA to DHA matter clinically — details that are rarely addressed in consumer supplement recommendations.
Magnesium is involved in hundreds of enzymatic processes in the brain and is frequently suboptimal in adults eating a Western diet. Evidence supports its use in depression and anxiety, and it is one of the few supplements with a genuinely favorable risk-benefit profile across a broad patient population. Formulation matters here too — not all magnesium compounds are bioequivalent.
B vitamins, particularly folate and B12, play critical roles in monoamine synthesis and methylation pathways relevant to depression and cognitive function. MTHFR polymorphisms affect folate metabolism in a clinically meaningful subset of patients. L-methylfolate — the active form of folate — has meaningful evidence as an adjunct in patients with depression who have not responded fully to antidepressants, particularly those with relevant genetic variants.
Vitamin D deficiency is highly prevalent and associated with depression, though the causal relationship is more complex than is often presented. Our psychiatrists assess vitamin D status in the context of the full clinical picture and make recommendations accordingly.
We are equally attentive to what the evidence does not support. Many popular supplements marketed for mental health — including numerous "nootropic" stacks, high-dose single nutrients outside their evidence base, and proprietary blends with undisclosed formulations — lack rigorous clinical trial data. We will tell you that directly, rather than recommend them because they are popular or because a patient requests them.
Supplement and medication interactions
This is an area that receives far too little attention in both conventional and integrative practice — and one where physician oversight is genuinely important.
Many commonly used supplements interact with psychiatric medications in ways that carry real clinical consequences. St. John's Wort, one of the most widely used supplements for depression, is a potent inducer of CYP450 enzymes and can significantly reduce the plasma levels of numerous psychiatric medications, including antidepressants, antipsychotics, and benzodiazepines — while also carrying serotonin syndrome risk when combined with serotonergic agents. High-dose omega-3s carry antiplatelet effects relevant in patients on anticoagulants. SAMe can precipitate mania in bipolar patients. Kava carries hepatotoxicity risk. Melatonin interacts with several psychiatric medications and has dose-dependent effects that are poorly understood by most patients taking it.
Our psychiatrists conduct a thorough review of all supplements a patient is taking as part of every comprehensive evaluation — not as a formality, but as a clinically meaningful assessment of what you are putting into your body and how it interacts with your medications and your neurobiology.
Sleep optimization
Sleep is not a passive backdrop to psychiatric illness — it is one of its most important determinants. Disrupted sleep precipitates and maintains depression, destabilizes mood in bipolar disorder, amplifies anxiety, and impairs the cognitive functions that make every other aspect of psychiatric treatment harder. Addressing sleep is not optional in comprehensive psychiatric care. It is central to it.
At Wave, sleep assessment is incorporated into every initial psychiatric evaluation. When sleep disturbance is identified — whether as a primary complaint or a contributing factor in a broader presentation — we approach it with the full clinical toolkit available.
This includes evidence-based behavioral interventions, most importantly Cognitive-Behavioral Therapy for Insomnia (CBT-I), which has the strongest evidence base of any treatment for chronic insomnia and is recommended as first-line over pharmacotherapy by sleep medicine guidelines. It includes careful evaluation of sleep hygiene, circadian disruption, and environmental factors. It includes judicious pharmacological management when indicated — with attention to the differential evidence base across sleep medications and the risks of long-term sedative-hypnotic use. And it includes assessment of whether underlying psychiatric conditions — depression, anxiety, bipolar disorder, PTSD — are driving sleep disruption and need to be addressed at that level.
We also counsel patients on evidence-based sleep optimization practices — light exposure timing, temperature, caffeine pharmacokinetics, alcohol's effect on sleep architecture, and the limited but real role of supplements such as melatonin and magnesium glycinate in specific clinical contexts.
Light therapy
Light therapy — the use of a high-intensity light source to modulate circadian rhythm and seasonal mood patterns — has a well-established evidence base for seasonal affective disorder (SAD) and emerging evidence for non-seasonal depression, bipolar depression, and circadian rhythm disruption. It is one of the few non-pharmacological interventions for mood disorders with consistent support from randomized controlled trials.
Our psychiatrists are familiar with the clinical evidence for light therapy and provide guidance on appropriate devices, intensity (10,000 lux is the standard), timing (morning use is generally most effective), duration of sessions, and contraindications — including the risk of mixed or manic episodes in bipolar patients, which is a real and underappreciated concern.
Light therapy is inexpensive, low-risk when used appropriately, and underutilized. For patients with seasonal mood patterns, circadian disruption, or depression that has not responded fully to other treatments, it is one of the first adjunctive interventions we discuss.
Mindfulness and meditation
The evidence base for mindfulness-based interventions in psychiatry has grown substantially over the past two decades. Mindfulness-Based Cognitive Therapy (MBCT) has the strongest evidence — it is recommended in clinical guidelines for the prevention of depressive relapse in patients with three or more prior episodes, with efficacy comparable to maintenance antidepressant therapy in some populations. Mindfulness-Based Stress Reduction (MBSR) has meaningful evidence for anxiety, chronic stress, and pain-related mood disturbance.
Our psychiatrists discuss mindfulness as a clinical intervention — not as a lifestyle aspiration. This means being specific about what the evidence supports, what form of practice is most relevant to a patient's presentation, and what realistic expectations should be. It also means being honest about the limits: mindfulness is not a treatment for acute psychiatric illness, and its benefits are most clearly established as adjunctive interventions and relapse prevention strategies in patients who have already achieved some degree of stability.
For patients interested in developing a mindfulness practice, we provide evidence-based guidance and can recommend structured programs — including app-based options with the strongest research support — as a complement to psychiatric treatment.
Lifestyle medicine
Physical health and mental health are not separate systems. The evidence connecting exercise, metabolic health, inflammatory burden, and social connection to psychiatric outcomes is substantial and should inform clinical practice.
Exercise has a meaningful evidence base as an adjunctive treatment for depression, with meta-analyses supporting effect sizes comparable to antidepressant medication in mild to moderate depression and significant additive effects in combination with pharmacotherapy. The mechanisms are multiple — monoaminergic, neuroplastic, anti-inflammatory, and circadian — and the side effect profile is favorable in ways that no medication can replicate.
Chronic inflammation is increasingly recognized as a contributor to treatment-resistant depression and is associated with a range of lifestyle factors including diet, sleep disruption, sedentary behavior, and psychosocial stress. While the clinical translation of inflammatory psychiatry research is still developing, our psychiatrists are familiar with the literature and incorporate relevant considerations into treatment planning for patients with refractory presentations.
Social connection — the quality and depth of a patient's relationships — is among the strongest predictors of psychiatric and overall health outcomes, with effect sizes that exceed most pharmacological interventions in population-level research. Addressing social isolation, relationship quality, and community engagement is a legitimate and underemphasized component of comprehensive psychiatric care.
How integrative psychiatry fits into your treatment at Wave
Integrative psychiatry at Wave is not a separate program or add-on service. It is woven into how our psychiatrists think about every patient. At your initial evaluation, your psychiatrist will take a thorough history that includes your diet, sleep, exercise habits, supplement use, and lifestyle context. Relevant integrative interventions are incorporated into your treatment plan alongside — not instead of — evidence-based pharmacological and psychotherapeutic approaches.
We do not recommend supplements or lifestyle interventions to replace medications that are working. We do not discourage patients from pursuing integrative approaches that have a reasonable evidence base and an acceptable risk profile. And we do not pretend that lifestyle optimization is sufficient treatment for serious psychiatric illness.
What we offer is honest, physician-level guidance on the full range of interventions that the science supports — delivered by psychiatrists who have taken the time to know the literature, not just the marketing.
Frequently Asked Questions
I am already taking a number of supplements. Can Wave help me evaluate whether they are appropriate?
Yes — and this is one of the most clinically valuable things we can offer. Many patients come to us with supplement regimens assembled from online recommendations, functional medicine practitioners, or direct-to-consumer testing services. Our psychiatrists will review what you are taking, assess the evidence base for each, evaluate potential interactions with any medications you are on, and provide honest guidance on what is worth continuing, what can be safely discontinued, and what may warrant concern.
Is there evidence that supplements can replace psychiatric medication?
For most patients with moderate to severe psychiatric illness, no — and we will say so directly. For patients with mild presentations, or as adjunctive treatment in patients who are already partially responding to medication, certain supplements have meaningful evidence as additions to a treatment plan. The decision about whether to pursue medication, supplements, or both is always made collaboratively, based on the severity of your illness, your prior treatment history, your preferences, and the honest evidence base for each option.